extra tirzepatide in vial Weight Loss Injections Both deliver the same medication,

Tirzepatide is a dual GIP and GLP-1 receptor agonist licensed for type 2 diabetes and weight management in the UK

The risks of not getting enough protein while taking a GLP-1 While some loss of muscle mass is bound to occur with dropping pounds on a GLP-1, if youre not supplying your body with substantial protein, youre at risk of losing even more of this essential tissue

While this has not been specifically demonstrated to cause clinically significant problems with antibiotics in practice, it represents a theoretical consideration for oral antibiotic absorption timing

At doses where the GLP-1 component is minimally active (discussed in the mechanism section above), the appetite-suppressing and motility-slowing effects may be minimal, and so might the nausea